November 24, 2021

November 24, 2021

ASH 2020: Dr. Davids Discusses Phase II AVO Study of Acalabrutinib + Venetoclax + Obinutuzumab for Chronic Lymphocytic Leukemia (CLL)

This video was recorded at the 62nd Annual Meeting of the American Society of Hematology, held virtually in December 2020. Dr. Davids specializes in CLL and serves on the CLL Society’s Medical Advisory Board.

November 24, 2021

CLL Society’s Tribune Ask and Tell Survey: Patient & Caregiver Feedback

During the third quarter of 2021, CLL Society conducted a poll among readers of The CLL Society Tribune about the COVID-19 pandemic and treatment decisions, mental health challenges, and taking medication. There were 138 respondents.

November 24, 2021

Did You Know Q4 2021

Dr. Allison J. Applebaum, Associate Attending Psychologist in the Department of Psychiatry and Behavioral Sciences at Memorial Sloan Kettering Cancer Center (MSK), and Assistant Professor of Psychology in Psychiatry at Weill Cornell Medical College provided us with important statistics about caregivers that we are sharing with you below.

November 24, 2021

Introduction to Immunity Part 4: Testing

As the immune system is complex, so is testing. The best testing for antigens is to isolate a protein large enough to be antigenic and specific enough so that it is only found in that one situation. You can choose a test for the presence of active inflammation

November 24, 2021

Introduction to Immunity Part 3

This article will repeat some of the earlier material, but you can still go back and reread them from past CLL Society Tribune editions, Introduction of Immunity Part 1 and Part 2. Let us put together all the factoids from the first two articles and see if we can

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

November 24, 2021

ASH 2020: Dr. Davids Discusses Phase II AVO Study of Acalabrutinib + Venetoclax + Obinutuzumab for Chronic Lymphocytic Leukemia (CLL)

CLL Society’s Tribune Ask and Tell Survey: Patient & Caregiver Feedback

Did You Know Q4 2021

Introduction to Immunity Part 4: Testing

Introduction to Immunity Part 3

CLL SOCIETY FAST FIND

QUICK LINKS

ABOUT US

CONTACT